MedCell - Human Regenerative Therapy

MedCell (the human division of Quy Biosciences Ltd.) is a UK based biotech company focussed on harnessing the power of stem cells to provide musculoskeletal regenerative therapeutics.

MedCell’s novel lead technologies cover cell therapy and cell expansion. These are two of the cornerstones of regenerative medicine which address unmet needs and provide significant advantages over current practice:

MS-ten - Stem cell treatments for tendon & ligament injuries

MedCell’s stem cell technology has already generated international revenues and the company has been recognised through awards for outstanding achievement in export and as a bioentrepreneurial company of the year.

The company boasts a breadth of commercial life sciences experience and is advised by world renowned academics and clinicians.

My Cart

There are no items in your cart.

VetCell Statistics

Percentage of racehorses that have returned to racing post treatment (this does not include 60 horses who were untraceable as we only have their stable name)

74.4%

Number of racehorses that have run more than 10 times since treatment

55

Racehorse wins post treatment

225

Racehorse placings 1st-3rd post treatment

598

Racehorse runs post treatment

1960

Racehorses treated

581

Total horses treated

1835

Scientifically proven

Sign up for our e-newsletter

PRODUCTS
  • StemRegen (Stem Cell Therapy) image

    Stem Cell Therapy (StemRegen)

  • StemRegen Bone Marrow Aspiration Kit image

    StemRegen Bone Marrow Aspiration Kit

  • StemRegen Transport Box image

    StemRegen Transport Box

  • E-PET (Equine Platelet Enhancement Therapy) image

    Equine Platelet Enhancement Therapy (E-PET)

  • HSP (Hoof Support Patch) image

    Hoof Support Patch (HSP)

  • Training image

    Training in StemRegen Procedures

Design By: Seamless Fusion | Developed and Built by: Simple IT Solutions